Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants
Clinical trial NCT05581823 · COMPLETED
Trial details
- NCT number
- NCT05581823
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2023-01-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.